PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France. View on ...

Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business ...

Sanofi is putting down $18 million across three historically Black medical schools as part of the French pharma's efforts to ...

The gift will be spread over 10 years and divided among Morehouse, Howard University College of Medicine and Meharry Medical ...

Morehouse School of Medicine may play a role in changing the lack of diversity in clinical testing as one of three historically Black medical schools receiving a $18 million gift from Sanofi, the ...

Sanofi and Sudair Pharma Company (SPC ... Our team, across some 100 countries, is dedicated to transforming the practice of ...

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...

Sanofi & Orano join forces to accelerate the development of develop next-generation radioligand medicines: Paris Friday, October 18, 2024, 10:00 Hrs [IST] Sanofi and Orano Med, a ...

Sanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024 ...